Skip to content
Axsome Therapeutics, Inc. (AXSM) Stock Price, Key Stats & Insider Trading
Home / Companies / AXSM AXS
Axsome Therapeutics, Inc. (AXSM) XNAS PHARMACEUTICAL PREPARATIONS Net insider selling (90d)
Latest AXSM Insider Trades
About Axsome Therapeutics, Inc. (AXSM) Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products include AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.
Headquarters NEW YORK, NY
Employees 925
Listed 2015
Exchange XNAS https://www.axsome.com SEC filings for AXSM on EDGAR
90-Day SEC Filing Activity Form 4 transaction type Transactions Shares Total value Open-market sale 13 201,352 $46.83M Grant or award 4 6,884 Option exercise 18 375,432
AXSM Insider Transactions (Form 4) 84 48 Form 4 filings on record, the earliest from Nov 20, 2024, newest first. Filing history page 2 of 2.
Date Insider Transaction Security Shares Price Value Jan 22, 2026 NP Nick Pizzie - Officer Option exercise Common Stock
Recent AXSM Form 8-K Filings 5
Recent AXSM Form 144 Notices of Proposed Sale 3 A Form 144 is notice of an INTENDED sale, not a completed one. It often precedes the Form 4 that reports the trade actually happening.
Filed Filer Relationship Shares Market value Notice Aug 6, 2026 Herriot Tabuteau Officer 4,660 $979K View on EDGAR Aug 5, 2026 Herriot Tabuteau Officer
AXSM Insider Trading - FAQ
What is the latest insider trade for AXSM? Axsome Therapeutics, Inc. (AXSM) had 14 insider filings in the last 90 days, with the most recent on 2026-08-07. The full record for AXSM runs to 48 Form 4 filings, the earliest from 2024-11-20. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
How many insiders are buying AXSM stock? No insider purchases of AXSM were filed in the last 90 days. 3 purchases are on record for this company.
How many insiders are selling AXSM stock? 13 insider sales of AXSM were filed in the last 90 days, totaling $46.83M.
Where can I see AXSM SEC filings (Form 4, 10-K, 10-Q, 8-K)? This page tracks AXSM Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
How can I follow AXSM insider buys? Create a free InsiderAlpha account and press Watch on this page to add AXSM to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
More Health Care Companies with Insider Activity Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Related Companies - Recent Insider Activity What is SEC Form 4? The filing insiders must submit within two business days of a trade, and how to read its transaction codes. Track AXSM insider activity as it files Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
Sign up free
Market cap $10.42B
P/E ratio -
Dividend yield -
Average volume 850.4K
52 week high $260.19
52 week low $112.90
Today's high $205.70
Today's low $199.00
Open $205.70
Volume 441.3K
Previous close $206.27
Shares outstanding 52.38M Market cap
$10.42B
925 employees
AXSM Insider Sentiment - Last 90 Days Share of open-market insider dollar volume that was buying versus selling, from SEC Form 4 filings.
0% Buying 100% Selling
0 insider purchases totaling $0 against 13 sales totaling $46.83M.
Most-Active AXSM Insiders - Last 90 Days 9 Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
Jan 22, 2026 NP Nick Pizzie - Officer Open-market sale Common Stock 12,000 $187.92 $2.26M
Jan 22, 2026 NP Nick Pizzie - Officer Option exercise Stock Option (Right to Buy) 12,000 $0.00 -
Jan 21, 2026 AM Ari Maizel - Officer Option exercise Common Stock 7,500 $70.73 $530K
Jan 21, 2026 AM Ari Maizel - Officer Open-market sale Common Stock 7,500 $184.44 $1.38M
Jan 21, 2026 AM Ari Maizel - Officer Option exercise Stock Option (Right to Buy) 7,500 $0.00 -
Jan 5, 2026 HT Herriot Tabuteau - Officer Option exercise Common Stock 78,703 $8.02 $631K
Jan 5, 2026 HT Herriot Tabuteau - Officer Open-market sale Common Stock 78,703 $171.28 $13.48M
Jan 6, 2026 HT Herriot Tabuteau - Officer Option exercise Common Stock 29,450 $8.02 $236K
Jan 6, 2026 HT Herriot Tabuteau - Officer Open-market sale Common Stock 29,450 $172.33 $5.08M
Jan 7, 2026 HT Herriot Tabuteau - Officer Option exercise Common Stock 31,261 $8.02 $251K
Jan 7, 2026 HT Herriot Tabuteau - Officer Open-market sale Common Stock 31,261 $170.38 $5.33M
Jan 5, 2026 HT Herriot Tabuteau - Officer Option exercise Stock Option (Right to Buy) 78,703 $0.00 -
Jan 6, 2026 HT Herriot Tabuteau - Officer Option exercise Stock Option (Right to Buy) 29,450 $0.00 -
Jan 7, 2026 HT Herriot Tabuteau - Officer Option exercise Stock Option (Right to Buy) 31,261 $0.00 -
Dec 31, 2025 MS Mark E. Saad Option exercise Common Stock 6,231 $8.02 $50K
Dec 31, 2025 MS Mark E. Saad Open-market sale Common Stock 6,231 $165.18 $1.03M
Dec 31, 2025 MS Mark E. Saad Option exercise Common Stock 31,346 $4.95 $155K
Dec 31, 2025 MS Mark E. Saad Open-market sale Common Stock 31,346 $165.18 $5.18M
Dec 31, 2025 MS Mark E. Saad Option exercise Stock Option (Right to Buy) 6,231 $0.00 -
Dec 31, 2025 MS Mark E. Saad Option exercise Stock Option (Right to Buy) 31,346 $0.00 -
Dec 2, 2025 HT Herriot Tabuteau - Officer Option exercise Common Stock 49,252 $8.02 $395K
Dec 2, 2025 HT Herriot Tabuteau - Officer Open-market sale Common Stock 49,252 $144.59 $7.12M
Dec 3, 2025 HT Herriot Tabuteau - Officer Option exercise Common Stock 20,163 $8.02 $162K
Dec 3, 2025 HT Herriot Tabuteau - Officer Open-market sale Common Stock 20,163 $146.94 $2.96M
Dec 4, 2025 HT Herriot Tabuteau - Officer Option exercise Common Stock 10,558 $8.02 $85K
Dec 4, 2025 HT Herriot Tabuteau - Officer Open-market sale Common Stock 10,558 $148.18 $1.56M
Dec 2, 2025 HT Herriot Tabuteau - Officer Option exercise Stock Option (Right to Buy) 49,252 $0.00 -
Dec 3, 2025 HT Herriot Tabuteau - Officer Option exercise Stock Option (Right to Buy) 20,163 $0.00 -
Dec 4, 2025 HT Herriot Tabuteau - Officer Option exercise Stock Option (Right to Buy) 10,558 $0.00 -
Nov 4, 2025 HT Herriot Tabuteau - Officer Option exercise Stock Option (Right to Buy) 50,459 $0.00 -
Nov 5, 2025 HT Herriot Tabuteau - Officer Option exercise Stock Option (Right to Buy) 21,775 $0.00 -
Nov 3, 2025 HT Herriot Tabuteau - Officer Option exercise Common Stock 91,705 $8.02 $735K
Nov 3, 2025 HT Herriot Tabuteau - Officer Open-market sale Common Stock 91,705 $132.34 $12.14M
Nov 4, 2025 HT Herriot Tabuteau - Officer Option exercise Common Stock 50,459 $8.02 $405K
Nov 4, 2025 HT Herriot Tabuteau - Officer Open-market sale Common Stock 50,459 $133.79 $6.75M
Nov 5, 2025 HT Herriot Tabuteau - Officer Option exercise Common Stock 21,775 $8.02 $175K
Nov 5, 2025 HT Herriot Tabuteau - Officer Open-market sale Common Stock 21,775 $134.49 $2.93M
Nov 3, 2025 HT Herriot Tabuteau - Officer Option exercise Stock Option (Right to Buy) 91,705 $0.00 -
Oct 6, 2025 HT Herriot Tabuteau - Officer Option exercise Common Stock 19,220 $8.02 $154K
Oct 6, 2025 HT Herriot Tabuteau - Officer Open-market sale Common Stock 19,220 $120.17 $2.31M
Oct 7, 2025 HT Herriot Tabuteau - Officer Option exercise Common Stock 13,390 $8.02 $107K
Oct 7, 2025 HT Herriot Tabuteau - Officer Open-market sale Common Stock 13,390 $118.77 $1.59M
Oct 8, 2025 HT Herriot Tabuteau - Officer Option exercise Common Stock 12,774 $8.02 $102K
Oct 8, 2025 HT Herriot Tabuteau - Officer Open-market sale Common Stock 12,774 $118.84 $1.52M
Oct 6, 2025 HT Herriot Tabuteau - Officer Option exercise Stock Option (Right to Buy) 19,220 $0.00 -
Oct 7, 2025 HT Herriot Tabuteau - Officer Option exercise Stock Option (Right to Buy) 13,390 $0.00 -
Oct 8, 2025 HT Herriot Tabuteau - Officer Option exercise Stock Option (Right to Buy) 12,774 $0.00 -
Sep 22, 2025 MJ Mark L. Jacobson - Officer Option exercise Common Stock 10,000 $2.85 $29K
Sep 22, 2025 MJ Mark L. Jacobson - Officer Open-market sale Common Stock 10,000 $115.96 $1.16M
Sep 22, 2025 MJ Mark L. Jacobson - Officer Option exercise Stock Option (Right to Buy) 10,000 $0.00 -
Sep 12, 2025 HT Herriot Tabuteau - Officer Option exercise Common Stock 27,907 $8.02 $224K
Sep 12, 2025 HT Herriot Tabuteau - Officer Open-market sale Common Stock 27,907 $118.96 $3.32M
Sep 15, 2025 HT Herriot Tabuteau - Officer Option exercise Common Stock 15,254 $8.02 $122K
Sep 15, 2025 HT Herriot Tabuteau - Officer Open-market sale Common Stock 15,254 $117.37 $1.79M
Sep 16, 2025 HT Herriot Tabuteau - Officer Option exercise Common Stock 19,719 $8.02 $158K
Sep 16, 2025 HT Herriot Tabuteau - Officer Open-market sale Common Stock 19,719 $114.19 $2.25M
Sep 12, 2025 HT Herriot Tabuteau - Officer Option exercise Stock Option (Right to Buy) 27,907 $0.00 -
Sep 15, 2025 HT Herriot Tabuteau - Officer Option exercise Stock Option (Right to Buy) 15,254 $0.00 -
Sep 16, 2025 HT Herriot Tabuteau - Officer Option exercise Stock Option (Right to Buy) 19,719 $0.00 -
Sep 16, 2025 MJ Mark L. Jacobson - Officer Open-market sale Common Stock 5,783 $116.19 $672K
Sep 16, 2025 MJ Mark L. Jacobson - Officer Option exercise Common Stock 25,000 $4.95 $124K
Sep 16, 2025 MJ Mark L. Jacobson - Officer Option exercise Common Stock 15,000 $4.85 $73K
Sep 16, 2025 MJ Mark L. Jacobson - Officer Open-market sale Common Stock 40,000 $114.23 $4.57M
Sep 16, 2025 MJ Mark L. Jacobson - Officer Option exercise Stock Option (Right to Buy) 25,000 $0.00 -
Sep 16, 2025 MJ Mark L. Jacobson - Officer Option exercise Stock Option (Right to Buy) 15,000 $0.00 -
Sep 8, 2025 MC Mark Coleman Open-market purchase Common Stock 800 $127.20 $102K
Sep 8, 2025 MC Mark Coleman Open-market purchase Common Stock 287 $127.30 $37K
Sep 8, 2025 MC Mark Coleman Open-market purchase Common Stock 488 $127.40 $62K
Sep 5, 2025 MS Mark E. Saad Option exercise Common Stock 9,127 $9.00 $82K
Sep 5, 2025 MS Mark E. Saad Open-market sale Common Stock 9,127 $125.07 $1.14M
Sep 5, 2025 MS Mark E. Saad Option exercise Stock Option (Right to Buy) 9,127 $0.00 -
Sep 2, 2025 RJ Roger Jeffs Open-market sale Common Stock 13,464 $123.68 $1.67M
Aug 27, 2025 RJ Roger Jeffs Open-market sale Common Stock 20,000 $122.30 $2.45M
Aug 28, 2025 RJ Roger Jeffs Open-market sale Common Stock 20,000 $121.60 $2.43M
Aug 29, 2025 RJ Roger Jeffs Open-market sale Common Stock 20,000 $121.27 $2.43M
Aug 22, 2025 RJ Roger Jeffs Open-market sale Common Stock 16,694 $120.08 $2.00M
Aug 26, 2025 RJ Roger Jeffs Open-market sale Common Stock 20,000 $120.03 $2.40M
Jun 6, 2025 RJ Roger Jeffs Grant or award Stock Option (Right to Buy) 3,166 $0.00 -
Jun 6, 2025 RJ Roger Jeffs Grant or award Restricted Stock Units 1,429 $0.00 -
Jun 6, 2025 MS Mark E. Saad Grant or award Stock Option (Right to Buy) 3,166 $0.00 -
Jun 6, 2025 MS Mark E. Saad Grant or award Restricted Stock Units 1,429 $0.00 -
Nov 19, 2024 MC Mark Coleman Option exercise Common Stock 33,410 $5.94 $198K
Nov 19, 2024 MC Mark Coleman Option exercise Stock Option (Right to Buy) 33,410 $0.00 -
$IONS
IONIS PHARMACEUTICALS INC
Herriot Tabuteau - OfficerOpen-market sale$9.54M
Nick Pizzie - Officer
